- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.89 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose(Non-covalent)
- 1 x LWU: 1-(2-(2-((6-(dihydroxymethyl)-2-phenylpyrimidin-4-yl)methylene)hydrazineyl)-2-oxoethyl)pyridin-1-ium(Non-covalent)
LWU.5: 15 residues within 4Å:- Chain A: Y.72, W.86, Y.124, E.202, X.203, W.286, S.293, V.294, F.295, R.296, F.297, Y.337, F.338, Y.341, H.447
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:Y.72
- Hydrogen bonds: A:Y.124, A:Y.124, A:S.293, A:R.296, A:Y.337, A:Y.337
- Water bridges: A:S.125
- pi-Stacking: A:W.86, A:W.86, A:W.286, A:W.286, A:Y.341
- 16 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 4 residues within 4Å:- Chain A: Q.413, R.417, N.533
- Ligands: MG.34
Ligand excluded by PLIPSO4.7: 5 residues within 4Å:- Chain A: L.386, H.387, P.388, E.389, D.390
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: T.504, G.506, A.507
Ligand excluded by PLIPSO4.9: 1 residues within 4Å:- Chain A: H.322
Ligand excluded by PLIPSO4.10: 5 residues within 4Å:- Chain A: G.240, M.241, G.242, E.243
- Ligands: MG.37
Ligand excluded by PLIPSO4.11: 2 residues within 4Å:- Chain A: F.80, K.348
Ligand excluded by PLIPSO4.12: 2 residues within 4Å:- Chain A: N.317, R.417
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain A: V.520, R.521, R.522
Ligand excluded by PLIPSO4.14: 3 residues within 4Å:- Chain A: R.493, D.494, P.495
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain B: Q.413, R.417, N.533, R.534
Ligand excluded by PLIPSO4.40: 4 residues within 4Å:- Chain B: T.504, A.505, G.506, A.507
Ligand excluded by PLIPSO4.41: 5 residues within 4Å:- Chain A: R.534
- Chain B: R.356, L.360, W.385
- Ligands: MG.33
Ligand excluded by PLIPSO4.42: 1 residues within 4Å:- Chain B: R.478
Ligand excluded by PLIPSO4.43: 3 residues within 4Å:- Chain B: R.16, S.57, G.58
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain B: K.23, R.136
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain A: R.522
- Chain B: H.387, R.393
Ligand excluded by PLIP- 31 x CL: CHLORIDE ION(Non-functional Binders)
CL.15: 1 residues within 4Å:- Chain A: A.467
Ligand excluded by PLIPCL.16: 1 residues within 4Å:- Chain A: R.177
Ligand excluded by PLIPCL.17: 2 residues within 4Å:- Chain A: R.16, G.58
Ligand excluded by PLIPCL.18: 1 residues within 4Å:- Chain A: D.372
Ligand excluded by PLIPCL.19: 3 residues within 4Å:- Chain A: N.233, P.312, E.313
Ligand excluded by PLIPCL.20: 2 residues within 4Å:- Chain A: K.23, R.136
Ligand excluded by PLIPCL.21: 3 residues within 4Å:- Chain A: R.525, A.526, Q.527
Ligand excluded by PLIPCL.22: 1 residues within 4Å:- Chain A: R.424
Ligand excluded by PLIPCL.23: 2 residues within 4Å:- Chain A: G.240, E.243
Ligand excluded by PLIPCL.24: 2 residues within 4Å:- Chain A: R.356
- Ligands: MG.32
Ligand excluded by PLIPCL.25: 1 residues within 4Å:- Chain A: H.284
Ligand excluded by PLIPCL.26: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.27: 1 residues within 4Å:- Chain A: Y.72
Ligand excluded by PLIPCL.28: 3 residues within 4Å:- Chain A: T.109, S.110, R.143
Ligand excluded by PLIPCL.46: 6 residues within 4Å:- Chain A: L.386
- Chain B: G.523, R.525, A.526, Q.527
- Ligands: MG.66
Ligand excluded by PLIPCL.47: 1 residues within 4Å:- Chain B: R.393
Ligand excluded by PLIPCL.48: 1 residues within 4Å:- Chain B: R.525
Ligand excluded by PLIPCL.49: 2 residues within 4Å:- Chain B: H.387, E.389
Ligand excluded by PLIPCL.50: 1 residues within 4Å:- Chain B: R.219
Ligand excluded by PLIPCL.51: 2 residues within 4Å:- Chain B: P.36, Y.98
Ligand excluded by PLIPCL.52: 1 residues within 4Å:- Chain B: P.44
Ligand excluded by PLIPCL.53: 2 residues within 4Å:- Chain B: G.264, T.267
Ligand excluded by PLIPCL.54: 1 residues within 4Å:- Ligands: MG.67
Ligand excluded by PLIPCL.55: 2 residues within 4Å:- Chain B: R.521, R.522
Ligand excluded by PLIPCL.56: 2 residues within 4Å:- Chain B: N.233, E.313
Ligand excluded by PLIPCL.57: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.58: 1 residues within 4Å:- Chain B: R.424
Ligand excluded by PLIPCL.59: 2 residues within 4Å:- Chain B: P.277, A.278
Ligand excluded by PLIPCL.60: 4 residues within 4Å:- Chain B: P.108, T.109, S.110, R.143
Ligand excluded by PLIPCL.61: 3 residues within 4Å:- Chain B: M.241, G.242
- Ligands: MG.67
Ligand excluded by PLIPCL.62: 1 residues within 4Å:- Chain B: R.475
Ligand excluded by PLIP- 5 x ZN: ZINC ION(Non-covalent)
ZN.29: 2 residues within 4Å:- Chain A: H.381
- Chain B: H.381
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain B- Metal complexes: A:H.381, B:H.381
ZN.30: 1 residues within 4Å:- Chain A: H.284
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:H.284
ZN.63: 2 residues within 4Å:- Chain A: H.381
- Chain B: H.381
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:H.381
ZN.64: 1 residues within 4Å:- Chain B: H.322
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:H.322
ZN.65: 1 residues within 4Å:- Chain B: X.203
No protein-ligand interaction detected (PLIP)- 14 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
MG.31: 1 residues within 4Å:- Chain A: H.253
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:H.253
MG.32: 1 residues within 4Å:- Ligands: CL.24
No protein-ligand interaction detected (PLIP)MG.33: 2 residues within 4Å:- Chain A: R.534
- Ligands: SO4.41
No protein-ligand interaction detected (PLIP)MG.34: 2 residues within 4Å:- Chain A: N.533
- Ligands: SO4.6
No protein-ligand interaction detected (PLIP)MG.35: 1 residues within 4Å:- Chain A: E.185
No protein-ligand interaction detected (PLIP)MG.36: 2 residues within 4Å:- Chain A: T.436, E.452
2 PLIP interactions:1 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:E.452, H2O.3
MG.37: 1 residues within 4Å:- Ligands: SO4.10
No protein-ligand interaction detected (PLIP)MG.38: 3 residues within 4Å:- Chain A: D.488, N.490, Q.499
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:D.488
MG.66: 5 residues within 4Å:- Chain B: R.525, A.526, Q.527, A.528
- Ligands: CL.46
No protein-ligand interaction detected (PLIP)MG.67: 5 residues within 4Å:- Chain B: G.240, G.242, E.243
- Ligands: CL.54, CL.61
No protein-ligand interaction detected (PLIP)MG.68: 2 residues within 4Å:- Chain B: M.241, R.245
No protein-ligand interaction detected (PLIP)MG.69: 1 residues within 4Å:- Chain B: H.253
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:H.253
MG.70: 3 residues within 4Å:- Chain B: M.85, T.436, E.452
2 PLIP interactions:1 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:E.452, H2O.6
MG.71: 2 residues within 4Å:- Chain B: S.371, D.372
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nachon, F. et al., Grid-Type Quaternary Metallosupramolecular Compounds Inhibit Human Cholinesterases through Dynamic Multivalent Interactions. Chembiochem (2022)
- Release Date
- 2023-06-14
- Peptides
- Acetylcholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.89 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose(Non-covalent)
- 1 x LWU: 1-(2-(2-((6-(dihydroxymethyl)-2-phenylpyrimidin-4-yl)methylene)hydrazineyl)-2-oxoethyl)pyridin-1-ium(Non-covalent)
- 16 x SO4: SULFATE ION(Non-functional Binders)
- 31 x CL: CHLORIDE ION(Non-functional Binders)
- 5 x ZN: ZINC ION(Non-covalent)
- 14 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nachon, F. et al., Grid-Type Quaternary Metallosupramolecular Compounds Inhibit Human Cholinesterases through Dynamic Multivalent Interactions. Chembiochem (2022)
- Release Date
- 2023-06-14
- Peptides
- Acetylcholinesterase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B